ArticleMolecular therapy : the journal of the American Society of Gene Therapy2019

Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing.

Jose Bonafont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.